연구동향 분석

Effect of co-administration of mTOR inhibitor with antioxidant on hepatic stellate cells activation and hepatic fibrosis

최윤영 2020년

논문상세정보
인용/피인용
' Effect of co-administration of mTOR inhibitor with antioxidant on hepatic stellate cells activation and hepatic fibrosis' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • Hepatic stellate cells
  • Immunosuppressive drugs
  • animal model
  • fibrosis
  • mtor inhibitor
  • n-acetyl cysteine
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
200 0

0.0%

' Effect of co-administration of mTOR inhibitor with antioxidant on hepatic stellate cells activation and hepatic fibrosis' 의 참고문헌

  • the New Burden in Liver Transplantation : How Should It Be Managed ? Visc Med , 201632:234 ?
    238
  • fibrosis -- fact or fantasy ?
    43 ( 2 Suppl 1 ) : S82-88 . [2006]
  • an integrated cellular response to tissue injury
    275 ( 4 ) :2247-2250 . [2000]
  • Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis
    24 ( 1 ) :176-184 [1996]
  • Thioacetamide-induced cirrhosis-like liver lesions in rats -usefulness and reliability of this animal model
    1988.l 34 ( 4 ) :229- 236
  • The natural history of hepatitis C cirrhosis after liver transplantation
    15 ( 9 ) :1063-1071 . [2009]
  • The histological course of nonalcoholic fatty liver disease : a longitudinal study of 103 patients with sequential liver biopsies
    42 ( 1 ) :132-138 [2005]
  • Tacrolimus ( FK506 ) prevents early stages of ethanol induced hepatic fibrosis by targeting LARP6 dependent mechanism of collagen synthesis
    8 ( 6 ) : e65897 . [2013]
  • TNFalpha in liver fibrosis
    3 ( 4 ) : p. 253-261 . [2015]
  • Successful conversion to rapamycin for calcineurin inhibitorrelated neurotoxicity following liver transplantation .
    37 ( 4 ) :1912-1914 . [2005]
  • Studies on the targeted delivery of the antifibrogenic compound mycophenolic acid to the hepatic stellate cell
    43 ( 5 ) :884-892 . [2005]
  • Standard operating procedures in experimental liver research : thioacetamide model in mice and rats
    49 ( 1 Suppl ) :21-29 [2015]
  • Reproducible production of thioacetamide-induced macronodularCirrhosis in the rat with no mortality .
    36 ( 4 ) :488-493 . [2002]
  • Rapamycin inhibits hepatic stellateCell proliferation in vitro and limits fibrogenesis in an in vivo model of liver fibrosis
    117 ( 5 ) :1198-1204 [1999]
  • Progelatinase A is produced and activated by rat hepatic stellateCells and promotes their proliferation
    30 ( 4 ) :977- 986 [1999]
  • Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis : a pilot study
    15 ( 10 ) :1667-1672 . [2002]
  • Oxidative stress-related molecules and liver fibrosis
    35 ( 2 ) :297-306 . [2001]
  • Oxidative stress effect on the activation of hepatic stellate cells
    42 ( 1 ) :1-8 . [2001]
  • Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease
    15 : 1814 ? 1820 [2009]
  • Non-alcoholic fatty liver disease following liver transplantation : a clinical review . Clin Transplant
    29 : 728 ? 737 [2015]
  • Mechanisms of spontaneous resolution of rat liver fibrosis . Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors
    102 ( 3 ) :538-549 . [1998]
  • Mechanisms of hepatic fibrogenesis
    134 ( 6 ) : p. 1655-1669 . [2008]
  • Mechanism of the diabetogenic action of cyclosporin A. Horm
    30 ( 11 ) :663-667 . [1998]
  • Liver stiffness 1 year after transplantation predicts clinical outcomes in patients with recurrent hepatitis C. Am
    14 ( 2 ) :375-383 [2014]
  • Liver necrosis induced by acute intraperitoneal ethanol administration in aged rats
    36 ( 3 ) :269-275 . [2002]
  • Liver fibrosis and repair : immune regulation of wound healing in a solid organ .
    14 ( 3 ) : p. 181-194 [2014]
  • Liver fibrogenesis and the role of hepatic stellate cells : new insights and prospects for therapy
    14 ( 7 ) :618-633 [1999]
  • Lethal hepatic injury by combined treatment of radiation plus chemotherapy in rats with thioacetamide-induced liver cirrhosis
    57 ( 1 ) :282-288 [2003]
  • Jr. Cirrhosis -- can we reverse hepatic fibrosis ?
    587 ) :100-112 . [2002]
  • Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis
    23 ( 5 ) :1189-1199 [1996]
  • Increased toxin-induced liver injury and fibrosis in interleukin-6-deficient mice
    31 ( 1 ) : p. 149-159 . [2000]
  • In vitro migratory potential of rat quiescent hepatic stellate cells and its augmentation by cell activation
    29 ( 6 ) :1760-1767 . [1999]
  • Implications of oxidative stress and hepatic cytokine ( TNF-alpha and IL-6 ) response in the pathogenesis of hepatic collagenesis in chronic arsenic toxicity
    204 ( 1 ) : p. 18-26 [2005]
  • Immunopathogenesis of hepatic fibrosis in chronic liver injury induced by repeatedly administered concanavalin A.
    11 ( 9 ) :1491-1500 . [1999]
  • How to modulate inflammatory cytokines in liver diseases
    26 ( 9 ) : p. 1029-1039 [2006]
  • Hemodynamic characterization of chronic bile duct-ligated rats : effect of pentobarbital sodium
    251 ( 2 Pt 1 ) : G176-180 . [1986]
  • Gene expression of interstitial collagenase in both progressive and recovery phase of rat liver fibrosis induced by carbon tetrachloride
    33 ( 2 ) :224-235 . [2000]
  • Fibrogenesis II . Metalloproteinases and their inhibitors in liver fibrosis
    279 ( 2 ) : G245- 249 [2000]
  • Fatty liver diseased and liver transplantation ? Where do we stand ?
    24 ( 14 ) :1491-1506 [2018]
  • Expression patterns of matrix metalloproteinases and their inhibitors in parenchymal and non-parenchymal cells of rat liver : regulation by TNF-alpha and TGF-beta1
    30 ( 1 ) :48-60 . [1999]
  • Expression patterns of cell cycle-related proteins in a rat cirrhotic model induced by CCl4 or thioacetamide .
    36 ( 1 ) :24-32 . [2001]
  • Expression of matrix metalloproteinases and their inhibitors during hepatic tissue repair in the rat
    113 ( 6 ) :443- 453 [2000]
  • Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients : a randomized controlled trial
    12 ( 11 ) :3008-3020 [2012]
  • Everolimus is a potent inhibitor of activated hepatic stellate cell functions in vitro and in vivo , while demonstrating anti-angiogenic activities
    126 ( 11 ) :775-784 . [2014]
  • Effects of hepatic stimulator substance , herbal medicine , selenium/vitamin E , and ciprofloxacin on cirrhosis in the rat
    110 ( 4 ) :1150-1155 . [1996]
  • Effect of antioxidants , resveratrol , quercetin , and Nacetylcysteine , on the functions of cultured rat hepatic stellate cells and Kupffer cells
    27 ( 5 ) :1265-1274 . [1998]
  • Disruption of tumor necrosis factor alpha receptor 1 signaling accelerates NAFLD progression in mice upon a high-fat diet
    58 : p. 17-27 [2018]
  • Diabetes mellitus after kidney transplantation in the United States
    3 ( 2 ) :178-185 . [2003]
  • Cyclosporine suppresses cell growth and collagen production in hepatic stellate cells
    37 ( 10 ) :4598-4602 [2005]
  • Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values
    37 ( 6 ) :1286- 1292 [2003]
  • Biomarkers of liver fibrosis : clinical translation of molecular pathogenesis or based on liver-dependent malfunction tests
    381 ( 2 ) :107-113 [2007]
  • Biologic basis for interleukin-1 in disease
    87 ( 6 ) : p. 2095-2147 . [1996]
  • Anti-TGF-beta strategies for the treatment of chronic liver disease
    29 ( 11 Suppl ) :121S-131S [2005]
  • Activins and activin antagonists in hepatocellular carcinoma
    14 ( 11 ) : p. 1699-1709 . [2008]
  • A simple method for the simultaneous isolation of stellate cells and hepatocytes from rat liver tissue
    248 ( 1-2 ) :97-102 [2003]
  • A dimethylnitrosamine-induced model of cirrhosis and portal hypertension in the rat
    1 ( 5 ) :489-499 . [1985]
  • 6. Bataller R & Brenner DA Liver fibrosis. J Clin Invest 115(2):209-218.
    115 ( 2 ) :209-218
  • 57. Perez Tamayo R. Is cirrhosis of the liver experimentally produced by CCl4 and adequate model of human cirrhosis? Hepatology, 1983. 3(1):112-120.
  • 25. Rockey DC Antifibrotic therapy in chronic liver disease. Clin Gastroenterol Hepatol, 2005 3(2):95-107.
  • 22. Gressner AM Hepatic fibrogenesis: the puzzle of interacting cells, fibrogenic cytokines, regulatory loops, and extracellular matrix molecules. Z Gastroenterol, 1992. 30 Suppl 1:5-16.